Bioelectron   Report issue

For profit Phase 2
Founded: Mountain View CA United States (2005)
Status: Acquired by PTC Therapeutics (2019)

Organization Overview

First Clinical Trial
2010
NCT01370447
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Edison Pharmaceuticals | EDISON THERAPS LLC